← Leaderboards
Mara Becker
Duke University
$6,798,777
Attributed
$6,798,777
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2019–21$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
Funding mix
By agency
NIH$6,798,777 · 1
By mechanism
N01$6,798,777 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Christoph Hornik$12,153,670
- Michael Cohen-Wolkowiez$47,908,561
- Kevin M Watt$9,629,862
- Fan Wang$27,559,340
- Daniel K Benjamin$109,874,279
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposAttention Deficit Hyperactivity DisorderChildhood LeukemiaAppearanceCeliac DiseaseAutism Spectrum DisorderAnatomyAffectBiologicalCaregiversConduct Clinical TrialsCharacteristicsChildChildhoodAdultBaseBest Pharmaceuticals For Children ActClinical ResearchClinical TrialsClinical Trials NetworkCohortComorbidityCongenital AbnormalityCoronary Arteriosclerosis
Grant awards (3)
CLINICAL PHARMACOKINETICS AND SAFETY TRIALS IN DOWN SYNDROME$1,500,903
N01 · FY2021 · HD · contact PI
CLINICAL PHARMACOKINETICS AND SAFETY TRIALS IN DOWN SYNDROME$2,298,706
N01 · FY2020 · HD · contact PI
CLINICAL PHARMACOKINETICS AND SAFETY TRIALS IN DOWN SYNDROME$2,999,168
N01 · FY2019 · HD · contact PI